PRKAA1 and neoplasm: Mechanistic studies have revealed that NBR2 inhibits GLUT1 expression and EMT, but promotes AMPK and acetyl-CoA carboxylase (ACC) activation in TC cells, thereby reducing the malignancy of TC and acting as a tumor suppressor (90, 91).